Mutation Identification and Monitoring of Three Distinct Clones in a Patient with Myelodysplastic/Myeloproliferative Disorder and Associated Systemic Mastocytosis

被引:0
|
作者
Belludi, C. K. [1 ]
Vnencak-Jones, C. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源
JOURNAL OF MOLECULAR DIAGNOSTICS | 2015年 / 17卷 / 06期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
H42
引用
收藏
页码:775 / 775
页数:1
相关论文
共 13 条
  • [1] Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases
    Mimiola, Elda
    Bomben, Riccardo
    De Matteis, Giovanna
    Perbellini, Omar
    Guglielmelli, Paola
    Bonifacio, Massimiliano
    Parisi, Alice
    Gattei, Valter
    Zamo, Alberto
    Mannelli, Francesco
    Garcia Montero, Andrs Celesteino
    Zanotti, Roberta
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (05) : 628 - 633
  • [2] C-kit activating mutation in a neonate with in-utero presentation of systemic mastocytosis associated with myeloproliferative disorder
    Kuint, J
    Bielorai, B
    Gilat, D
    Birenbaum, E
    Amariglio, N
    Rechavi, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (03) : 838 - 839
  • [3] Distinct clones are associated with the development of transient myeloproliferative disorder and acute megakaryocytic leukemia in a patient with Down syndrome
    Kanegane, Hirokazu
    Watanabe, Sayaka
    Nomura, Keiko
    Xu, Gang
    Ito, Etsuro
    Miyawaki, Toshio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 86 (03) : 250 - 252
  • [4] Distinct Clones are Associated with the Development of Transient Myeloproliferative Disorder and Acute Megakaryocytic Leukemia in a Patient with Down Syndrome
    Hirokazu Kanegane
    Sayaka Watanabe
    Keiko Nomura
    Gang Xu
    Etsuro Ito
    Toshio Miyawaki
    International Journal of Hematology, 2007, 86 (3) : 250 - 252
  • [5] Successful Imatinib Treatment for Systemic Mastocytosis Associated With Myelodysplastic/Myeloproliferative Neoplasm: Report of a Case and Literature Review
    Barozzi, Enrico
    Bucelli, Cristina
    Grifoni, Federica Irene
    Gianelli, Umberto
    Iurlo, Alessandra
    Cattaneo, Daniele
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [6] The Pivotal Role of Whole Genome and Transcriptome Sequencing in a Rare Case of Systemic Mastocytosis with Associated Myelodysplastic/Myeloproliferative Neoplasm with Neutrophilia
    Strasser, Bernhard
    Hoermann, Gregor
    Haushofer, Alexander
    CLINICAL CHEMISTRY, 2024, 70 (01) : 350 - 352
  • [7] Efficacy of lenalidomide in a patient with systemic mastocytosis associated with SF3B1-mutant myelodysplastic syndrome
    Sarmiento, Marcela
    Rocca, Gabriela S.
    Rahhal, Marilina
    Lincango Yupanki, Marco
    Zubieta, Martin
    Metrebian, Fernanda
    Narbaitz, Marina
    Larripa, Irene B.
    Belli, Carolina B.
    LEUKEMIA & LYMPHOMA, 2021, 62 (12) : 3027 - 3030
  • [8] Detection of the KITD816V mutation in myelodysplastic and/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosis
    Craig, Jeffrey W.
    Hasserjian, Robert P.
    Kim, Annette S.
    Aster, Jon C.
    Pinkus, Geraldine S.
    Hornick, Jason L.
    Steensma, David P.
    Lindsley, R. Coleman
    DeAngelo, Daniel J.
    Morgan, Elizabeth A.
    MODERN PATHOLOGY, 2020, 33 (06) : 1135 - 1145
  • [10] Systemic mastocytosis associated with chronic idiopathic myelofibrosis -: A distinct subtype of systemic mastocytosis-associated clonal hematological nonmast cell lineage disorder carrying the activating point mutations KITD816V and JAK2V61'7F
    Sotlar, Karl
    Bache, Anja
    Stellmacher, Florian
    Bueltmann, Burkhard
    Valent, Peter
    Horny, Hans-Peter
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (01): : 58 - 66